These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1340 related articles for article (PubMed ID: 26291816)

  • 41. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
    Zueff LF; Martins WP; Vieira CS; Ferriani RA
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome.
    Adali E; Yildizhan R; Kurdoglu M; Bugdayci G; Kolusari A; Sahin HG
    Fertil Steril; 2010 Jul; 94(2):666-72. PubMed ID: 19368913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non-obese Saudi women.
    Daghestani MH
    Int J Gynaecol Obstet; 2018 Aug; 142(2):162-169. PubMed ID: 29745981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.
    Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q
    Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.
    Guzel EC; Celik C; Abali R; Kucukyalcin V; Celik E; Guzel M; Yilmaz M
    Gynecol Endocrinol; 2014 Jun; 30(6):419-22. PubMed ID: 24524360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
    Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of serum adiponectin levels in women with polycystic ovarian syndrome.
    Itoh H; Kawano Y; Furukawa Y; Matsumoto H; Yuge A; Narahara H
    Clin Exp Obstet Gynecol; 2013; 40(4):531-5. PubMed ID: 24597249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.
    Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J
    J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
    Mejia-Montilla J; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Bravo-Henríquez A
    Endocrinol Nutr; 2012 Jan; 59(1):21-7. PubMed ID: 22115703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
    Chen Y; Wang XJ; Jin HL; Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
    Gupta V; Mishra S; Mishra S; Gupta V
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume.
    Huang R; Yue J; Sun Y; Zheng J; Tao T; Li S; Liu W
    Clin Chim Acta; 2015 Oct; 450():366-9. PubMed ID: 26387454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
    Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
    Mejia-Montilla J; Álvarez-Mon M; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Suarez-Torres I; Bravo-Henríquez A
    Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
    Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
    Ságodi L; Lombay B; Vámosi I; Barkai L
    Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
    Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
    Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.